Baxter Healthcare Corporation

← The SEC Ephemeris: the whole map

Baxter Healthcare Corporation DAPZURA RT

In the graph: all 3 documents (7 pages).

Application: NDA 218224
Ticker: Baxter Healthcare Corporation
Product: DAPZURA RT
Disease area: Not yet classified
Response path: Not yet classified
Complete Response Letters: March 29, 2024 · March 27, 2024 · April 29, 2021

From FDA letters and SEC filings. Not investment or medical advice.

Group by

Build queue · replay at pipeline speed